hp6

The Minister for Health and Medical Services Mr Jone Usamate launched the Color Explosion Fiji 2016 “Rang De Viti” meaning “Let’s Color Fiji” program at the Waterfront Hotel in Lautoka last week.

This event, now in its second year, is ideally developed to encourage people to engage in physical activities and enjoy a healthy life, moving away from the deadly effects andt burdens of NCDs.

The actual Rand De VGiti will be held on the 30th of January in Lautoka and it is anticipated that there will be an influx of participants compared to last year.

Participants at the program will walk 5.7 km wearing a white t-shirt and as they pass a colour pit stop, they will be showered with color powder, finishing in a rainbow of hues.

The organising president of the color explosion Dr Ram Raju said that the committee intends to raise fund through the program which will eventually be directed to the wellness outreach program, and has welcomed the support of people around Fiji. “We want to create and capture an opportunity for the people of Fiji to visit Lautoka as often people in Lautoka move to other areas such Nadi or Suva to attend events”, said Mr Raju.

Minister Usamate applauded the initiative of the Color Explosion and has welcomed their continued partnership with the Health Ministry for future projects.

Last Updated on 9 years by Publishing Team

Explore More

COVID-19 Update 27-06-2022

COVID-19 Update Monday 27th June Transmission Update: Since the last update, we have recorded 95 new cases of which 48 new cases were recorded on 24/06/2022; 8 new cases were

MEDIA RELEASE 5: 2019 NOVEL CORONAVIRUS

This morning, at 0800 Fiji time, WHO’s Director General, Dr Tedros Ghebreyesus, on advisement of the International Health Regulations (IHR) Emergency Committee on the novel coronavirus (2019-nCoV), declared a Public

AstraZeneca Vaccination Update

Media Release                                                                    COVID-19 Vaccination April 8th 2021 Fiji’s Ministry of Health and Medical Services shares the position of the United Kingdom Medicines and Healthcare Products Regulatory Agency and the European